SPRI | Pharmacologic Therapy Of Ocular Disease (2017 EN)

Discussion in 'Medicine' started by Kanka, Jul 11, 2017.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,395
    Likes Received:
    485
    Trophy Points:
    83
    [​IMG]

    Author: Scott M. Whitcup (Editor), Dimitri T. Azar (Editor)
    Full Title: Pharmacologic Therapy Of Ocular Disease
    Publisher: Springer; 1st ed. 2017 edition (June 7, 2017)
    Year: 2017
    ISBN-13: 9783319582900 (978-3-319-58290-0), 9783319582887 (978-3-319-58288-7)
    ISBN-10: 3319582909, 3319582887
    Pages: 394
    Language: English
    Genre: Biomedical Sciences: Pharmacology & Toxicology
    File type: PDF (True)
    Quality: 10/10
    Price: 330.63 €


    There have been major advancements in the pharmacologic treatment of eye diseases over the past decade. With newly discovered disease targets and novel approaches to deliver therapeutic compounds to the eye, patients are seeing improved outcomes. Not only are there better treatments for diseases where treatments existed, we now have effective therapy for previously untreatable and blinding eye disorders. This volume will cover the pharmacologic treatment of eye diseases from the front of the eye including eyelids, conjunctiva and cornea all the way back to the retina and optic nerve. The first section of the volume reviews general principles of ocular pharmacology, pharmacokinetics, pharmaceutical sciences, and drug delivery. In addition, the volume provides an up to date guide to the pharmacologic approach to the key eye diseases that threaten sight or ocular function.

    -------------
     
    Last edited by a moderator: Dec 9, 2019